HTR7 and cancer: The data from the Cancer Therapeutics Response Portal (CTRP) showed that HTR7 expression was positively correlated with IC50 of several drugs, including chlorambucil, hydrochloride, insular, and vorinostat, implying that these drugs may be resistant to high HTR7 expression (Fig 12B).